* Metacrine, Inc. MTCR.OQ reported a quarterly adjusted loss
of 57 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 51 cents per share.
* Reported revenue was zero; analysts expected zero.
* Metacrine, Inc.'s reported EPS for the quarter was a loss
of 57 cents.
* The mean earnings estimate of analysts had fallen by
about 1.3% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Metacrine, Inc. shares had fallen by 42.3% this quarter and
lost 54.5% so far this year.
* The company reported a quarterly loss of $14.77 million.
* Wall Street's median 12-month price target for Metacrine, Inc.
is $19.66
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated May 14 at 01:23 a.m. GMT.
All figures in US dollars